CHE vs MS
Chemed Corp (CHE) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Chemed Corp (CHE) is a medical care facilities company listed on NYSE.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported CHE revenue for 2024-12-31 was $2.43B. Net income was $302.0M. Revenue was up 7.4% from 2023-12-31 to 2024-12-31. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
MS does not have a complete income-statement cache yet.
CHE currently screens at market cap $5.79B and trailing P/E 23.8. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the CHE and MS stock pages for the full models.
Not investment advice.